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A corrigendum on
Ontogeny of innate T lymphocytes – some innate lymphocytes are more innate than others
by Vermijlen D, Prinz I. Front Immunol (2014) 5:486. doi: 10.3389/fimmu.2014.00486
We have found an error in our review article “Ontogeny of innate T lymphocytes – some innate
lymphocytes are more innate than others.”
On page 6, under the section “Mucosa-associated invariant T cells”:
“In humans, this TCR consists of Vα7.2–Jα22: : :.”
Instead of “Jα22,” this should be “Jα33.”
The same error is present in Table 1, under “MAIT – Human,” row “(Semi-)invariant TCR”:
should be Jα33.
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